| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 06/02/2004 | EP1165748B1 Method and apparatus for ultrasonic lysis of biological cells |
| 06/02/2004 | EP1147210A4 Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth |
| 06/02/2004 | EP0891376B1 Antifungal peptides from scleroderma texense |
| 06/02/2004 | EP0815210B1 An enzyme with aminopeptidase activity |
| 06/02/2004 | EP0807178B1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 06/02/2004 | CN1500882A Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells |
| 06/02/2004 | CN1500863A A microorganism in which the fadr gene is knocked out and a process for producing l-threonine using the microorganism |
| 06/02/2004 | CN1152136C Polypeptide having 5-aminolevulinic acid synthase activity and nucleic acid encoding same |
| 06/02/2004 | CN1152133C Levo-diketoreductase |
| 06/02/2004 | CN1151799C Bacterial membrane fractions with adjuvant effect |
| 06/01/2004 | US6743908 For use in cancer diagnosis and therapy |
| 06/01/2004 | US6743896 Protien for use in the treatment of infection and tumors |
| 06/01/2004 | US6743616 Highly productive alpha-amylases |
| 06/01/2004 | US6743611 For encoding clover yellow vein virus nuclear inclusion-a proteins; proteases; aminopeptidases |
| 06/01/2004 | US6743607 Production of complex carbohydrates |
| 06/01/2004 | US6743577 Methods of using cyanovirins to inhibit viral infection |
| 06/01/2004 | US6743431 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/01/2004 | US6743353 Method and apparatus for neutralizing alkaline wastewater without using mineral acids |
| 06/01/2004 | CA2078571C Bacillus thuringiensis cryiiic gene and protein toxic to coleopteran insects |
| 06/01/2004 | CA2063176C Process for the preparation of glutarylacylase in large quantities |
| 06/01/2004 | CA2037677C Process for production of exogenous gene or its product in plant cells |
| 05/27/2004 | WO2004044214A1 Novel substance fki-1033 and process for producing the same |
| 05/27/2004 | WO2004044213A1 Novel polyhydroxy alkanoate copolymer including within molecule unit having vinyl group or carboxyl group in side chain, and producing method therefor |
| 05/27/2004 | WO2004044186A1 Probiotic additive and the production method thereof |
| 05/27/2004 | WO2004044031A1 New polyhydroxyalkanoate comprising unit having (phenylmethyl)oxy structure on side chain thereof, and method for producing the same |
| 05/27/2004 | WO2004029270A3 Process for producing vitamin b6 |
| 05/27/2004 | WO2004016727A9 Determination and/or control of reactor environmental conditions |
| 05/27/2004 | WO2003054550A3 Uses of an endothelial cell receptor |
| 05/27/2004 | WO1999046281A8 Novel polypeptides and nucleic acids encoding the same |
| 05/27/2004 | US20040102349 Textiles, hard surfaces; storage stability |
| 05/27/2004 | US20040101963 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus |
| 05/27/2004 | US20040101931 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 05/27/2004 | US20040101837 Nucleotide sequences coding for proteins involved in the biosynthesis of L-serine, an improved method for the microbial production of L-serine and a genetically modified microorganism suitable therefor |
| 05/27/2004 | CA2504309A1 Novel substance fki-1033 and process for producing the same |
| 05/26/2004 | EP1422294A1 Method of making an HPV18 L1 Expression Vector and HPV18 L1,L2 antibodies |
| 05/26/2004 | EP1421947A1 p53 vaccine |
| 05/26/2004 | EP1421202A2 Method for producing vitamin b12 |
| 05/26/2004 | EP1421195A1 SURFACE EXPRESSION VECTORS HAVING pgsBCA, THE GENE CODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND A METHOD FOR EXPRESSION OF TARGET PROTEIN AT THE SURFACE OF MICROORGANISM USING THE VECTOR |
| 05/26/2004 | EP1421102A2 Method for making acylated polypeptides |
| 05/26/2004 | EP1421098A2 Surface proteins of streptococcus pyogenes |
| 05/26/2004 | EP1421095A1 Assay for detection of human parvovirus b19 nucleic acid |
| 05/26/2004 | EP1421055A1 Methods for the synthesis of amines such as ephedrine and intermediates |
| 05/26/2004 | EP1165104B1 Lactobacillus parcasei strain capable of preventing diarrhoea |
| 05/26/2004 | EP0995121B1 C-peptide specific assay procedure |
| 05/26/2004 | CN1500145A Method for sectetion and prodn. of protein |
| 05/26/2004 | CN1499976A Caloporoside derivatives, methods for prodn. thereof and their use |
| 05/26/2004 | CN1151264C Agrobacterium mediated transformation of moulds, in particular those belonging to genus aspergillus |
| 05/25/2004 | US6740742 Nucleotide sequences encoding the dapC gene and process for the production of L-lysine |
| 05/25/2004 | US6740505 Culturing eukaryotic cells which produce proteins in a medium which comprises an alkanoic acid and/or salt at a maintained concentration |
| 05/25/2004 | US6740485 Identification of genes responsible for the virulence of staphylococcus bacteria, which allows for identification of new anti-bacterial agents and mutants that can be used as vaccines |
| 05/25/2004 | CA2261576C Probes for detecting and identifying helicobacter pylori |
| 05/25/2004 | CA2157369C Arylalkanoic acid resolution |
| 05/25/2004 | CA2112096C Dna sequences of the human papillomavirus type 42 and diagnostic application thereof |
| 05/21/2004 | WO2004041905A1 New polyhydroxyalkanoate copolymer, resin composition, molded product, toner, image forming method and image forming apparatus |
| 05/21/2004 | WO2004041858A2 Improving growth characteristics of filamentous microorganisms |
| 05/21/2004 | WO2004040988A1 Fishes treated with lactic acid bacterium culture medium having antibacterial and antixoidative effects |
| 05/21/2004 | WO2003089462A3 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
| 05/21/2004 | WO2003072725A3 Recombinant negative strand virus rna expression systems and vaccines |
| 05/21/2004 | WO2003050275A8 Method of isolation and purification of trypsin from pronase and use thereof |
| 05/21/2004 | CA2505400A1 Improving growth characteristics of filamentous microorganisms |
| 05/21/2004 | CA2502565A1 Fishes treated with lactic acid bacterium culture medium having antibacterial and antioxidative effects |
| 05/20/2004 | US20040098762 Comprises nucleotide sequences coding desaturase for insertion of a double bond into a fatty acyl moiety at the twelfth or fifteenth carbon position in fatty acyl chain; improving vegetable oils |
| 05/20/2004 | US20040097721 Pesticidal toxins and genes from Bacillus laterosporus strains |
| 05/20/2004 | US20040097402 Therapy for infections; bactericides; synergistic mixtures |
| 05/20/2004 | US20040096921 Human plasma hyaluronidase |
| 05/20/2004 | US20040096875 Comprises polynucleotide derived from rise; genetic engineering |
| 05/20/2004 | US20040096434 Agent for relieving intestinal disorders comprising live bacterial cells of a strain belonging to Lactobacillus helveticus, wherein said strain exhibits minimum growth inhibitory concentration of 0.8% or more dry solid bile in a |
| 05/19/2004 | EP1419780A1 Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of senile dementia and Alzheimer's disease |
| 05/19/2004 | EP1021553B1 Eukaryotic gene expression cassette and uses thereof |
| 05/19/2004 | EP1010753B1 Fermented soy-milk prepared with bifidobacterium breve yit 4065 |
| 05/19/2004 | EP0941227B1 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent |
| 05/19/2004 | EP0920493B1 Biodegradation of explosives |
| 05/19/2004 | EP0870010B1 Fungal food |
| 05/19/2004 | EP0832253B1 Nucleic acid respiratory syncytial virus vaccines |
| 05/19/2004 | EP0787190B1 Hepatitis e virus antigens and uses therefor |
| 05/19/2004 | EP0711173B1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 05/19/2004 | EP0682703B1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
| 05/19/2004 | EP0650525B1 D-n-carbamoyl-amino acid amidohydrolase and hydantoinase |
| 05/19/2004 | CN1498273A Stereoselective reduction of substituted acotophenone |
| 05/19/2004 | CN1498270A Gene disrupted yeast |
| 05/19/2004 | CN1498265A Thermophilic microoganism bacillus coagulans strain SIM-TDSM 14043 for production of L(+)-lactate from fermentable sugars and their mixtures |
| 05/19/2004 | CN1497048A Method for preparing 3-heteroarylradical-3-hydroxy-propionic acid derivative |
| 05/19/2004 | CN1497046A Alpha ketonic acid reductase and its preparation method, and method of preparing optical active alpha hydroxy acid using said reductase |
| 05/19/2004 | CN1496994A Method for reducing content of sugar in light corn extrcution |
| 05/19/2004 | CN1150333C Method for producing nucleic acid substances |
| 05/19/2004 | CN1150323C Gene for enzyme having both alkaline pullulanse and alkaline alpha-amylase activities |
| 05/19/2004 | CN1150314C Immunity enhancing lactic acid bacteria |
| 05/19/2004 | CN1150313C Method for the production of polypeptides |
| 05/19/2004 | CN1150207C Gclq receptor, HIV-1 ph120 region binding thereto, and related peptides and targeting antibodies |
| 05/19/2004 | CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein |
| 05/18/2004 | US6737413 SOX-9 gene and protein and use in the regeneration of bone or cartilage |
| 05/18/2004 | US6737273 Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 05/18/2004 | US6737259 Modified with polyethylene glycol for treatment and inhibition of cancer and metastasis |
| 05/18/2004 | US6737256 Generating preferential compound in culture; obtain genetically engineered bacteria, culturing, recover preferential compound |
| 05/18/2004 | US6737255 Mutant ilvH gene and method for producing L-valine |
| 05/18/2004 | US6737248 Apparatus for use in the detection of bacterial infections |
| 05/18/2004 | US6737241 Methods for screening for transdominant intracellular effector peptides and RNA molecules |
| 05/18/2004 | US6737065 Method for producing mushroom mycelia and uses thereof |
| 05/18/2004 | US6737059 Methods of inhibiting inflammatory processes and alleviating symptoms associated with multiple sclerosis |
| 05/18/2004 | CA2289553C Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid |